311 related articles for article (PubMed ID: 27819060)
1. The Hidden Conundrum of Phosphoinositide Signaling in Cancer.
Thapa N; Tan X; Choi S; Lambert PF; Rapraeger AC; Anderson RA
Trends Cancer; 2016 Jul; 2(7):378-390. PubMed ID: 27819060
[TBL] [Abstract][Full Text] [Related]
2. Phosphatidylinositol Phosphate 5-Kinase Iγ and Phosphoinositide 3-Kinase/Akt Signaling Couple to Promote Oncogenic Growth.
Thapa N; Choi S; Tan X; Wise T; Anderson RA
J Biol Chem; 2015 Jul; 290(30):18843-54. PubMed ID: 26070568
[TBL] [Abstract][Full Text] [Related]
3. Regulation of PI3K effector signalling in cancer by the phosphoinositide phosphatases.
Rodgers SJ; Ferguson DT; Mitchell CA; Ooms LM
Biosci Rep; 2017 Feb; 37(1):. PubMed ID: 28082369
[TBL] [Abstract][Full Text] [Related]
4. The phosphatidylinositol (PI)-5-phosphate 4-kinase type II enzyme controls insulin signaling by regulating PI-3,4,5-trisphosphate degradation.
Carricaburu V; Lamia KA; Lo E; Favereaux L; Payrastre B; Cantley LC; Rameh LE
Proc Natl Acad Sci U S A; 2003 Aug; 100(17):9867-72. PubMed ID: 12897244
[TBL] [Abstract][Full Text] [Related]
5. Phosphatidylinositol (3,4) bisphosphate-specific phosphatases and effector proteins: A distinct branch of PI3K signaling.
Li H; Marshall AJ
Cell Signal; 2015 Sep; 27(9):1789-98. PubMed ID: 26022180
[TBL] [Abstract][Full Text] [Related]
6. Importance of phosphoinositide binding by human β-defensin 3 for Akt-dependent cytokine induction.
Phan TK; Lay FT; Hulett MD
Immunol Cell Biol; 2018 Jan; 96(1):54-67. PubMed ID: 29359392
[TBL] [Abstract][Full Text] [Related]
7. PI(3,4,5)P3 and PI(3,4)P2 levels correlate with PKB/akt phosphorylation at Thr308 and Ser473, respectively; PI(3,4)P2 levels determine PKB activity.
Ma K; Cheung SM; Marshall AJ; Duronio V
Cell Signal; 2008 Apr; 20(4):684-94. PubMed ID: 18249092
[TBL] [Abstract][Full Text] [Related]
8. Following the trail of lipids: Signals initiated by PI3K function at multiple cellular membranes.
Naguib A
Sci Signal; 2016 May; 9(428):re4. PubMed ID: 27188443
[TBL] [Abstract][Full Text] [Related]
9. Emerging evidence of signalling roles for PI(3,4)P2 in Class I and II PI3K-regulated pathways.
Hawkins PT; Stephens LR
Biochem Soc Trans; 2016 Feb; 44(1):307-14. PubMed ID: 26862220
[TBL] [Abstract][Full Text] [Related]
10. Phosphoinositides: Two-Path Signaling in Neuronal Response to Oligomeric Amyloid β Peptide.
Uranga RM; Alza NP; Conde MA; Antollini SS; Salvador GA
Mol Neurobiol; 2017 Jul; 54(5):3236-3252. PubMed ID: 27080543
[TBL] [Abstract][Full Text] [Related]
11. Lipid-dependent Akt-ivity: where, when, and how.
Siess KM; Leonard TA
Biochem Soc Trans; 2019 Jun; 47(3):897-908. PubMed ID: 31147387
[TBL] [Abstract][Full Text] [Related]
12. TAPP Adaptors Control B Cell Metabolism by Modulating the Phosphatidylinositol 3-Kinase Signaling Pathway: A Novel Regulatory Circuit Preventing Autoimmunity.
Jayachandran N; Mejia EM; Sheikholeslami K; Sher AA; Hou S; Hatch GM; Marshall AJ
J Immunol; 2018 Jul; 201(2):406-416. PubMed ID: 29884706
[TBL] [Abstract][Full Text] [Related]
13. TGFβ receptor endocytosis and Smad signaling require synaptojanin1, PI3K-C2α-, and INPP4B-mediated phosphoinositide conversions.
Aki S; Yoshioka K; Takuwa N; Takuwa Y
Mol Biol Cell; 2020 Mar; 31(5):360-372. PubMed ID: 31913757
[TBL] [Abstract][Full Text] [Related]
14. Regulation of B-cell activation and differentiation by the phosphatidylinositol 3-kinase and phospholipase Cgamma pathway.
Marshall AJ; Niiro H; Yun TJ; Clark EA
Immunol Rev; 2000 Aug; 176():30-46. PubMed ID: 11043766
[TBL] [Abstract][Full Text] [Related]
15. The lipid products of phosphoinositide 3-kinase isoforms in cancer and thrombosis.
Anquetil T; Payrastre B; Gratacap MP; Viaud J
Cancer Metastasis Rev; 2018 Sep; 37(2-3):477-489. PubMed ID: 29868934
[TBL] [Abstract][Full Text] [Related]
16. PI 3-kinases and PTEN: how opposites chemoattract.
Comer FI; Parent CA
Cell; 2002 May; 109(5):541-4. PubMed ID: 12062096
[TBL] [Abstract][Full Text] [Related]
17. Phosphatidylinositol Kinases and Phosphatases in
Nakada-Tsukui K; Watanabe N; Maehama T; Nozaki T
Front Cell Infect Microbiol; 2019; 9():150. PubMed ID: 31245297
[TBL] [Abstract][Full Text] [Related]
18. INPP4B and PTEN Loss Leads to PI-3,4-P2 Accumulation and Inhibition of PI3K in TNBC.
Reed DE; Shokat KM
Mol Cancer Res; 2017 Jun; 15(6):765-775. PubMed ID: 28196852
[TBL] [Abstract][Full Text] [Related]
19. PI3K signaling in cancer: beyond AKT.
Lien EC; Dibble CC; Toker A
Curr Opin Cell Biol; 2017 Apr; 45():62-71. PubMed ID: 28343126
[TBL] [Abstract][Full Text] [Related]
20. Agonist-stimulated phosphatidylinositol-3,4,5-trisphosphate generation by scaffolded phosphoinositide kinases.
Choi S; Hedman AC; Sayedyahossein S; Thapa N; Sacks DB; Anderson RA
Nat Cell Biol; 2016 Dec; 18(12):1324-1335. PubMed ID: 27870828
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
